financetom
Business
financetom
/
Business
/
OpenAI to build its first European data centre in Norway, with partners
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI to build its first European data centre in Norway, with partners
Jul 31, 2025 8:14 AM

OSLO (Reuters) -OpenAI is launching its first Stargate data centre project in Europe, partnering with developer Nscale Global Holdings and investment group Aker ASA ( AKAAF ) to open a $1-billion facility in Norway next year, the companies said on Thursday.

The artificial intelligence partnership, called Stargate Norway, will initially install 100,000 Nvidia ( NVDA ) processors and could see a tenfold expansion in future phases amid soaring AI demand, the companies said.

The centre, to be built near Narvik in northern Norway, is the first in Europe under OpenAI's Stargate programme and follows the recent announcement of similar-sized Stargate UAE in the United Arab Emirates, the U.S. tech firm said.

The gigafactory will be fully powered by renewable energy from local hydropower production, the companies added.

"Infrastructure like this is really important and unlocks a ton of potential for developers, researchers, scientists, and startups all across Norway and Europe," OpenAI CEO Sam Altman said in a video presentation.

The shares of Norwegian conglomerate Aker ASA ( AKAAF ) rose 11% to a two-year high of 729 Norwegian crowns before paring gains to trade at 717 crowns at 1337 GMT.

Nscale and Aker ( AKAAF ) will jointly own Stargate Norway with 50% stakes each, investing about $1 billion for the initial phase of the project, which will consume about 20 megawatts of electrical power capacity and have OpenAI as its first customer.

Aker ( AKAAF ) said it was working with local power producer Nordkraft to secure access to enough electricity to allow Stargate to increase its consumption to 230 MW and eventually add a further 290 MW.

An Aker ( AKAAF ) spokesperson declined to comment on investment costs beyond the initial commitment or a time frame for the additional capacity.

The facility will run on Nvidia's ( NVDA ) advanced GB300 Superchip processors, connected by the U.S. company's high-speed NVLink network technology, Nvidia ( NVDA ) CEO Jensen Huang said in the video presentation.

The facility will be among the first AI gigafactories in Europe, Nscale CEO Josh Payne said in the statement.

"Sovereign, scalable, and sustainable infrastructure is now essential to remain competitive," he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
nCino Could Benefit From Robust Bank Tech Spending Under Trump Administration, Morgan Stanley Says
nCino Could Benefit From Robust Bank Tech Spending Under Trump Administration, Morgan Stanley Says
Dec 2, 2024
12:17 PM EST, 12/02/2024 (MT Newswires) -- nCino's (NCNO) organic subscription revenue for fiscal Q4 and fiscal 2026 may be at risk amid a gradual mortgage acceleration, but the upcoming Trump presidency could spur demand, Morgan Stanley said Monday in a note. The investment firm said it agrees with the view that a Trump administration could spur an acceleration in...
Duke Energy Unit Lowers Customer Rates by 4.5% in North Carolina
Duke Energy Unit Lowers Customer Rates by 4.5% in North Carolina
Dec 2, 2024
12:18 PM EST, 12/02/2024 (MT Newswires) -- Duke Energy ( DUK ) said Monday that its Duke Energy Progress unit has reduced rates for residential customers in North Carolina by 4.5% as part of its annual fuel cost adjustment. The North Carolina Utilities Commission approved the adjustment, which took effect on Sunday, on Nov. 13, the utility said. A typical...
Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says
Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says
Dec 2, 2024
12:16 PM EST, 12/02/2024 (MT Newswires) -- Applied Therapeutics ( APLT ) faces uncertainty after the US Food and Drug Administration rejected the company's new drug application for its drug candidate govorestat in classic galactosemia, a genetic metabolic disorder, due to deficiencies in the clinical application, UBS Securities said in a report Monday. The company disclosed last week the health...
Vitalhub Increases Credit Facilities to $65 Million
Vitalhub Increases Credit Facilities to $65 Million
Dec 2, 2024
12:18 PM EST, 12/02/2024 (MT Newswires) -- Vitalhub ( VHIBF ) on Monday said it increased its credit facilities with the Bank of Nova Scotia to $65 million from $33 million. The health-technologies company said the facilities consist of a $60-million term facility and a $5-million revolving facility, with the option to increase by an additional $10 million. The increased...
Copyright 2023-2026 - www.financetom.com All Rights Reserved